Skip to main content

Vagifem News

Major Women's Health Study Supports Hormone Replacement Therapy in Early Menopause

WEDNESDAY, May 1, 2024 – Hormone replacement therapy can safely ease middle-aged women’s symptoms during early menopause, data from a major women’s health study show. Women younger than 60 can use ho...

Oral Contraceptives May Protect Against Rheumatoid Arthritis

WEDNESDAY, Nov. 8, 2023 – Oral contraceptive use appears to protect against rheumatoid arthritis (RA), while menopausal hormone therapy (MHT) use may increase the risk for late-onset RA, according...

FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause

PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ – Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem (estradiol vaginal...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Atrophic Vaginitis

Vagifem patient information at Drugs.com